Nu-Med Plus (NUMD) Amortization - Intangibles (2016 - 2017)
Nu-Med Plus' (NUMD) quarterly Amortization - Intangibles came in at $21508.0 in Q1 2017, up 412.84% year-on-year from $4193.9 in Q1 2016, and down 70.31% quarter-over-quarter from $72450.0 in Q4 2016.
Nu-Med Plus (NUMD) Amortization - Intangibles (2016 - 2017) Analysis & Trends
Nu-Med Plus has disclosed Amortization - Intangibles across 2 years of filings, most recently posting $21508.0 for Q1 2017.
- Amortization - Intangibles for Q1 2017 came in at $21508.0, up 412.84% year-over-year; the trailing twelve-month figure through Dec 2017 was $21508.0 (down 58.5% YoY), and the FY2017 annual result was -$21508.0, down 141.5% from the prior year.
- Amortization - Intangibles came in at $21508.0 for Q1 2017 at Nu-Med Plus, down from $72450.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $72450.0 in Q4 2016 to a low of -$6875.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 21,508.00 |
| Dec 31, 2016 | 72,450.00 |
| Sep 30, 2016 | -6,875.00 |
| Jun 30, 2016 | -6,875.00 |
| Mar 31, 2016 | -6,875.00 |